ALPHA TRIBE

Borosil Scientific LimitedPPTs, 22-05-2025: Investor Presentation

22-05-2025 | 10:34 am

1. Financial Highlights:

Borosil Scientific reported consolidated net sales of ₹129.5 Cr for the quarter, rising 11.9% YoY, and ₹438.5 Cr for FY25, up 10.7%. Q4 EBITDA stood at ₹19.2 Cr with a 14.8% margin, slightly lower YoY, while FY25 EBITDA grew 19.2% to ₹60.4 Cr, improving margins to 13.8%. Q4 PAT was ₹8.6 Cr (-8.9% YoY), but FY25 PAT increased 13.8% to ₹26.7 Cr. The company ended FY25 with a net cash position of ₹106.3 Cr. Growth was mainly driven by scientific segment sales, particularly lab consumables and equipment, with a small domestic glassware dip.

2. Strategic Initiatives & Growth Drivers:

Focus remains on innovation through R&D, expanding filter papers, environmental testing products, and lab equipment. Leveraging brand strength and ‘Make in India’ to boost exports and enter new markets. Medium-term targets include sustaining 12-14% revenue CAGR, improving EBITDA margins in Process Sciences and lab equipment, and enhancing energy efficiency with projects like the 450 kW solar rooftop.

3. Business Developments:

Expanded pharma packaging capacity and entered new verticals via acquisitions such as Goel Scientific. Launched advanced lab equipment under LabQuest and integrated process systems more deeply. Current portfolio spans 4000+ SKUs across laboratory glassware, equipment, process systems, and pharma packaging.

4. Market Position & Competitive Advantage:

India’s largest lab glassware maker with strong footholds in pharma (58% of scientific sales), government research, and education sectors. Benefits from trusted brand, 150+ channel partners, exports to 90+ countries, and certifications including ISI and global quality standards, reinforcing leadership and scale advantages.

5. Investor Implications:

Strong top-line growth, margin improvement opportunities, and net cash position suggest positive growth potential. Expansion in high-margin Process Sciences and international markets could enhance profitability. Execution on launches and acquisitions is key to sustaining momentum. Renewable energy and ESG efforts add operational resilience worth watching.

No comments yet. Be the first to comment!

All announcements from Borosil Scientific Limited